Did you know that there are currently 38 clinical studies and researches being carried out at Pantai Hospital Kuala Lumpur to improve quality of care and clinical outcomes? These are driven by none other than Malaysia Operation’s first Research & Innovation Department set up in November last year.
Senior Research Scientist Dr Wong Shin Yee, a PhD holder in Molecular Medicine, heads the new department, supported by a team of experienced study coordinators and research assistants. For months now, they have been working with different stakeholders on the 38 approved studies that span multiple medical fields.
Cancer therapy is the current research focus, with 14 oncology clinical trials underway relating to breast cancer and non-small cell lung carcinoma. In addition, there are five oncology studies initiated by the consultants at Pantai Hospital Kuala Lumpur to determine the clinical outcomes of cancer patients at Pantai Hospital Kuala Lumpur.
The team is making good headway and looks forward to share their research outcomes soon. Stay tuned.
Related Stories
Gleneagles Hong Kong and HKTDC Co-organised a Thematic Session at The Asia Summit on Global Health 2026
Titled “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution”, the thematic panel session co-organised by Gleneagles Hong Kong and Hong Kong Trade Development Council (HKTDC) was moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia.
Acibadem Performed Türkiye's First Experimental 5G‑Supported Remote Robotic Surgical Simulation
The simulation was conducted between Acibadem Maslak Hospital and Acibadem University CASE (Advanced Medical Simulation and Training Center).
Gleneagles JPMC performs first VARIPULSE procedure in Borneo
Cardiovascular Laboratory at Gleneagles JPMC continues to evolve, marked by new milestones in advanced heart rhythm procedures.
Stronger Together as One IHH, North Asia
Leaders, doctors, nurses and staff from Gleneagles Hospital Hong Kong and Parkway Shanghai, under IHH North Asia, recently participated in an offsite team-building experience designed to strengthen collaboration, connection and shared thinking across markets and functions.
Shaping the Future of Oncology at Fortis Cancer Summit 2026
Held on 1–3 May 2026 in New Delhi, the Fortis Cancer Summit 2026 brought together healthcare leaders, oncology experts and clinicians from around the world to exchange insights, strengthen partnerships and shape the future of cancer care.
-(1).png?sfvrsn=c64976f_1)
Advancing Care Across Every Stage of the Cancer Journey: Lessons for Life 2026
Mount Elizabeth Hospitals and Parkway Cancer Centre brought clinicians, partners and the community together at Lessons for Life 2026 to reflect on the progress of cancer care and the collective work needed to support patients across every part of their journey.
